in the same period
- Patients completed full 2 year ACTION3 study treatment increased from 32 to 40
- Patients enrolled over into Open Label Extension Study increased from 31 to 39
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix to Present at ASX CEO Connect
DXB
dimerix limited
Add to My Watchlist
2.80%
!
55.0¢

Ann: Dimerix to Present at ASX CEO Connect, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
55.0¢ |
Change
0.015(2.80%) |
Mkt cap ! $324.6M |
Open | High | Low | Value | Volume |
54.0¢ | 57.0¢ | 53.8¢ | $742.9K | 1.353M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 50789 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 3577 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 50789 | 0.540 |
5 | 112991 | 0.535 |
11 | 155097 | 0.530 |
3 | 109895 | 0.525 |
4 | 267346 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 3577 | 1 |
0.555 | 2189 | 1 |
0.560 | 54633 | 6 |
0.565 | 99941 | 3 |
0.570 | 24091 | 2 |
Last trade - 14.03pm 24/06/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |